BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 240033)

  • 41. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extensive proliferation of subsequently injected marrow cells in parental-to-F1 hematopoietic chimeras that restored normal stem cell concentration after initial transplantation.
    Sonoda T; Hayashi C; Seike H; Nakayama H; Terasaka K; Morioka T; Nakano T; Kitamura Y
    Exp Hematol; 1985 Feb; 13(2):143-50. PubMed ID: 2857651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ; Emeson EE; Veith FJ
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic regulation of hematopoietic stem cell exhaustion during development and growth.
    Yuan R; Astle CM; Chen J; Harrison DE
    Exp Hematol; 2005 Feb; 33(2):243-50. PubMed ID: 15676219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R
    Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of genetic resistance to friend virus leukemia in mice.
    Kumar V; Bennett M; Eckner RJ
    J Exp Med; 1974 May; 139(5):1093-109. PubMed ID: 4596510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
    Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correspondence re: Mary S. Leffell and Joseph H. Coggin, Jr. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection. Cancer Res., 37: 4112--4119, 1977.
    Basombrio MA
    Cancer Res; 1978 Oct; 38(10):3568-9. PubMed ID: 80267
    [No Abstract]   [Full Text] [Related]  

  • 59. Spontaneous rejection of intradermally transplanted non-engineered tumor cells by neutrophils and macrophages from syngeneic strains of mice.
    Ibata M; Takahashi T; Shimizu T; Inoue Y; Maeda S; Tashiro-Yamaji J; Okada M; Ueda K; Kubota T; Yoshida R
    Microbiol Immunol; 2011 Oct; 55(10):726-35. PubMed ID: 21806674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymus-derived lymphocyte-dependent rejection of syngeneic papovavirus (SV40) and methylcholanthrene tumors in inbred hamsters.
    Blasecki JW
    J Immunol; 1977 Nov; 119(5):1621-6. PubMed ID: 199667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.